Enabling Clinical Trials of Disease-Modifying Therapies for Huntington’s Disease

Enabling Clinical Trials of Disease-Modifying Therapies for Huntington’s Disease

Publication date: Nov 27, 2019

Lauren Byrne of University College London discusses how ultrasensitive biomarker detection technology is making a huge impact in the study of Huntington’s Disease at the 2019 Powering Precision Health Summit in Barcelona, Spain.

Concepts Keywords
Atrophy Natural history disease
Barcelona Sorry technology
Bean Bio markers
Biomarker Competition metal
Biomarkers Drug targeting
Blood Medicine
Blood Test Clinical medicine
Brain Branches of biology
Brain Death Biomarkers
Chess Cerebral atrophy
Clinical Trial
Clinical Trials
Cognitive
Cognitive Impairment
Cuticle
Dhe
Diagnostic Test
Drug Target
Emery
Esso
Fax
Filament
Fluid
Foam
Ford
Fraud
Genetic
Genetic Test
Genome
Global Brain
Hedge
Hitch
Hops
Hunting
Huntington
Imp
Justin Gray
Kodi
Light Spectrum
London
Lot
Matrix
Meat
Memory
Mutant
Mutation
Natural History
Nerve
NFL
Pathology
Pharma
PhD
Plasma
Prognosis
Protocol
Satellite
Spain
Spectrum
Tea
Thes
Tin
Trade Secret
Whistle

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *